Cutaneous melanoma in the era of molecular profiling
- 1 August 2009
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 374 (9687), 362-365
- https://doi.org/10.1016/s0140-6736(09)61397-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Vaccine trials in melanoma—time for reflectionNature Reviews Clinical Oncology, 2009
- Oncogenic Braf Induces Melanocyte Senescence and Melanoma in MiceCancer Cell, 2009
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative RegimensJournal of Clinical Oncology, 2008
- Overcoming Immunologic Tolerance to Melanoma: Targeting CTLA-4 with Tremelimumab (CP-675,206)The Oncologist, 2008
- Microscopic Tumor Burden in Sentinel Lymph Nodes Predicts Synchronous Nonsentinel Lymph Node Involvement in Patients With MelanomaJournal of Clinical Oncology, 2008
- Distribution and Significance of Occult Intraepidermal Tumor Cells Surrounding Primary MelanomaJournal of Investigative Dermatology, 2008
- Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trialThe Lancet, 2008
- Improving Melanoma Classification by Integrating Genetic and Morphologic FeaturesPLoS Medicine, 2008
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Distinct Sets of Genetic Alterations in MelanomaNew England Journal of Medicine, 2005